After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Earlier, Yahoo Finance discussed this stock as it revealed Bausch Health Announces Fourth-Quarter and Full-Year 2023 Results.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Bausch Health Companies Inc is listed on the NYSE in the Healthcare sector while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Bausch Health Companies Inc is $3.35B. A total of 3.47 million shares were traded on the day, compared to an average of 2.11M shares.
In the most recent transaction, Carson Seana sold 220 shares of BHC for 7.38 per share on Dec 05. After the transaction, the EVP, General Counsel now owns 382,925 company shares. In a previous transaction on Nov 06, Carson Seana sold 43 shares at 7.61 per share. BHC shares that EVP, General Counsel owns now total 384,836.
Among the insiders who sold shares, Carson Seana disposed of 6,685 shares on Sep 06 at a per-share price of $8.28. This resulted in the EVP, General Counsel holding 385,213 shares of BHC after the transaction. In another insider transaction, Carson Seana sold 292 shares at $9.32 per share on Feb 28. Company shares held by the EVP, General Counsel now total 359,185.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for BHC in the last 3 months, the mean price target is $9.50 with high estimates of $14.00 and low estimates of $7.00. In terms of 52-week highs and lows, BHC has a high of $10.23 and a low of $5.57.
As of this writing, BHC has an earnings estimate of $0.7 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of $0.82 per share and a lower estimate of $0.51. The company reported an EPS of $1.02 in the last quarter, which was 10.90% higher than expectations of $0.92.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. BHC’s latest balance sheet shows that the firm has $582.00M in Cash & Short Term Investments as of fiscal 2021. There were $22.65B in debt and $5.20B in liabilities at the time. Its Book Value Per Share was -$2.80, while its Total Shareholder’s Equity was -$34.00M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BHC is Buy with a score of 3.17.
